# Nyxoah (NYXH) — News

NYXH · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/nyxh/news

## Recent headlines

- [NyxOah - Appoints Liam Kelly as CEO effective October 1, 2026 succeeding Olivier Taelman](https://www.ainvest.com/news/nyxoah-appoints-liam-kelly-ceo-effective-october-1-2026-succeeding-olivier-taelman-2609) — AInvest Wire, Sep 28, 2026
- [NyxOah appoints Liam Kelly as chief executive officer](https://www.ainvest.com/news/nyxoah-appoints-liam-kelly-chief-executive-officer-2609) — AInvest Wire, Sep 28, 2026
- [NyxOah SA: Reaffirms full year 2026 financial guidance](https://www.ainvest.com/news/nyxoah-sa-reaffirms-full-year-2026-financial-guidance-2609) — AInvest Wire, Sep 21, 2026
- [NyxOah announces chief financial officer transition](https://www.ainvest.com/news/nyxoah-announces-chief-financial-officer-transition-2609) — AInvest Wire, Sep 21, 2026
- [NyxOah's Genio shows zero device-related serious adverse events](https://www.ainvest.com/news/nyxoah-genio-shows-device-related-adverse-events-2609) — AInvest Wire, Sep 2, 2026
  On August 8, 2025, the U.S. Food and Drug Administration (FDA) approved Nyxoah’s Genio system for the treatment of moderate to severe obstructive sleep apnea (OSA) in patients with an AHI between 15 and 65 events per hour. The approval was based on results from the DREAM trial, a prospective…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).